Surang said her team of researchers had found that tetrahydrocannabinol and cannabinol , which are extracted from cannabis, can stop the growth of lung cancer cells in mice and thus offer the promise of becoming new anti-lung cancer agents in humans.
“Our clinical trials in the laboratory and on animals of the lung cancer treatment proficiency of three major cannabinoid compounds – THC, CBD and CBN – showed that THC and CBN can effectively deter cancer growth, confirming the potential of using cannabis to treat lung cancer in humans,” she said. Arthit said the university had contacted some major hospitals to work together on human trials in the development of cannabinoid medicine for treating lung cancer.